<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">(.%) </span>
   <span class="font23">the </span>
   <span class="font20">and </span>
   <span class="font17">patients </span>
   <span class="font16">with </span>
   <span class="font15">were </span>
   <span class="font14">was </span>
   <span class="font14">treatment </span>
   <span class="font14">psychiatric </span>
   <span class="font13">(.–.) </span>
   <span class="font12">for </span>
   <span class="font12">group </span>
   <span class="font12">{background </span>
   <span class="font12">The </span>
   <span class="font12">HCV </span>
   <span class="font11">study </span>
   <span class="font11">(%) </span>
   <span class="font11">(range) </span>
   <span class="font11">margin </span>
   <span class="font11">median </span>
   <span class="font11">{border-style </span>
   <span class="font11">hepatitis </span>
   <span class="font11">not </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">(.% </span>
   <span class="font11">DAAs </span>
   <span class="font11">among </span>
   <span class="font11">= .). </span>
   <span class="font11">reported </span>
   <span class="font11">subjects </span>
   <span class="font11">two </span>
   <span class="font11">who </span>
   <span class="font11">[]. </span>
   <span class="font11">before </span>
   <span class="font11">therapy </span>
   <span class="font11">Patients </span>
   <span class="font11">disorders </span>
   <span class="font11">higher </span>
   <span class="font11">SVR- </span>
   <span class="font11">according </span>
   <span class="font11">due </span>
   <span class="font11">had </span>
   <span class="font11">have </span>
   <span class="font11">more </span>
   <span class="font11">our </span>
   <span class="font11">vs. </span>
   <span class="font10">(–) </span>
   <span class="font10">.%, </span>
   <span class="font10">AEs </span>
   <span class="font10">comorbidity </span>
   <span class="font10">observed </span>
   <span class="font10">one </span>
   <span class="font10">this </span>
   <span class="font10">antiviral </span>
   <span class="font10">chronic </span>
   <span class="font10">clinical </span>
   <span class="font10">drug </span>
   <span class="font10">during </span>
   <span class="font10">from </span>
   <span class="font10">these </span>
   <span class="font10">ART </span>
   <span class="font10">SVR </span>
   <span class="font10">adverse </span>
   <span class="font10">all </span>
   <span class="font10">are </span>
   <span class="font10">based </span>
   <span class="font10">which </span>
   <span class="font10">(N = ) </span>
   <span class="font10">Group </span>
   <span class="font10">between </span>
   <span class="font10">data </span>
   <span class="font10">follow-up </span>
   <span class="font10">least </span>
   <span class="font10">lower </span>
   <span class="font10">that </span>
   <span class="font10">treated </span>
   <span class="font10">use </span>
   <span class="font10">virus </span>
   <span class="font10">&amp;lt; . </span>
   <span class="font10">. ± . </span>
   <span class="font10">HCV-infected </span>
   <span class="font10">RBV </span>
   <span class="font10">Table </span>
   <span class="font10">after </span>
   <span class="font10">anti-HCV </span>
   <span class="font10">baseline </span>
   <span class="font10">drugs </span>
   <span class="font10">genotype </span>
   <span class="font10">patient </span>
   <span class="font10">patients, </span>
   <span class="font10">patients. </span>
   <span class="font10">population </span>
   <span class="font10">px; </span>
   <span class="font10">recent </span>
   <span class="font10">score </span>
   <span class="font10">symptoms </span>
   <span class="font10">{font-family </span>
   <span class="font10">HCV-RNA </span>
   <span class="font10">SOF </span>
   <span class="font10">also </span>
   <span class="font10">anxiety </span>
   <span class="font10">change </span>
   <span class="font10">compared </span>
   <span class="font10">events </span>
   <span class="font10">failure </span>
   <span class="font10">font-size </span>
   <span class="font10">including </span>
   <span class="font10">lost </span>
   <span class="font10">number </span>
   <span class="font10">only </span>
   <span class="font10">plus </span>
   <span class="font10">previous </span>
   <span class="font10">psychotic </span>
   <span class="font10">rate </span>
   <span class="font10">risk </span>
   <span class="font10">therapeutic </span>
   <span class="font10">(/, </span>
   <span class="font10">Among </span>
   <span class="font10">DAA </span>
   <span class="font10">DAA-based </span>
   <span class="font10">DAA-treatment </span>
   <span class="font10">Severe </span>
   <span class="font10">and/or </span>
   <span class="font10">antipsychotic </span>
   <span class="font10">available </span>
   <span class="font10">been </span>
   <span class="font10">characteristics </span>
   <span class="font10">differences </span>
   <span class="font10">direct-acting </span>
   <span class="font10">double; </span>
   <span class="font10">evaluated </span>
   <span class="font10">frequently </span>
   <span class="font10">included </span>
   <span class="font10">mean </span>
   <span class="font10">mostly </span>
   <span class="font10">neuropsychiatric </span>
   <span class="font10">other </span>
   <span class="font10">safety </span>
   <span class="font10">severe </span>
   <span class="font10">such </span>
   <span class="font10">(.%), </span>
   <span class="font10">(SD) </span>
   <span class="font10">(group </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">DDIs </span>
   <span class="font10">HCV-infection </span>
   <span class="font10">HCV-monoinfected </span>
   <span class="font10">HIV </span>
   <span class="font10">However, </span>
   <span class="font10">IDU </span>
   <span class="font10">MSM </span>
   <span class="font10">Psychiatric </span>
   <span class="font10">This </span>
   <span class="font10">achieved </span>
   <span class="font10">associated </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">can </span>
   <span class="font10">depression </span>
   <span class="font10">did </span>
   <span class="font10">dose </span>
   <span class="font10">even </span>
   <span class="font10">experienced </span>
   <span class="font10">liver </span>
   <span class="font10">mg/dL, </span>
   <span class="font10">p-value </span>
   <span class="font10">prescribed </span>
   <span class="font10">profile </span>
   <span class="font10">proportion </span>
   <span class="font10">rates </span>
   <span class="font10">regarding </span>
   <span class="font10">regimens </span>
   <span class="font10">response </span>
   <span class="font10">solid; </span>
   <span class="font10">starting </span>
   <span class="font10">studies </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">those </span>
   <span class="font10">total </span>
   <span class="font10">treatment. </span>
   <span class="font10">virological </span>
   <span class="font10">whom </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%). </span>
   <span class="font10">= .), </span>
   <span class="font10">Adverse </span>
   <span class="font10">All </span>
   <span class="font10">EOT </span>
   <span class="font10">European </span>
   <span class="font10">FIB- </span>
   <span class="font10">HCV/HIV-coinfected </span>
   <span class="font10">Liver </span>
   <span class="font10">Moreover, </span>
   <span class="font10">achieving </span>
   <span class="font10">antidepressant </span>
   <span class="font10">antipsychotics </span>
   <span class="font10">bold </span>
   <span class="font10">changes </span>
   <span class="font10">considering </span>
   <span class="font10">courier; </span>
   <span class="font10">course </span>
   <span class="font10">defined </span>
   <span class="font10">disorder </span>
   <span class="font10">drug-drug </span>
   <span class="font10">em; </span>
   <span class="font10">first </span>
   <span class="font10">groups </span>
   <span class="font10">groups. </span>
   <span class="font10">has </span>
   <span class="font10">high </span>
   <span class="font10">individuals </span>
   <span class="font10">infected </span>
   <span class="font10">infection </span>
   <span class="font10">infection, </span>
   <span class="font10">interactions </span>
   <span class="font10">into </span>
   <span class="font10">intravenous </span>
   <span class="font10">leading </span>
   <span class="font10">main </span>
   <span class="font10">major </span>
   <span class="font10">majority </span>
   <span class="font10">most </span>
   <span class="font10">occurred </span>
   <span class="font10">performed </span>
   <span class="font10">population, </span>
   <span class="font10">presented </span>
   <span class="font10">prevalence </span>
   <span class="font10">probably </span>
   <span class="font10">pt;} </span>
   <span class="font10">received </span>
   <span class="font10">regimen </span>
   <span class="font10">remaining </span>
   <span class="font10">research </span>
   <span class="font10">should </span>
   <span class="font10">some </span>
   <span class="font10">sustained </span>
   <span class="font10">using </span>
   <span class="font10">visit </span>
   <span class="font10">well </span>
   <span class="font10">while </span>
  </p>
 </body>
</html>
